Avidity Biosciences, Inc. ($RNAM)
Filing Information
| Accession Number | 0001193125-26-082300 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 27, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
721,352
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Feb 27, 2026 | Sale to Issuer | 133,977 | โ | โ | 0 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 92,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 131,250 | โ | โ | 0 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 148,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 60,125 | โ | โ | 0 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 106,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 50,000 | โ | โ | 0 | Direct | โ | View Details |